Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Transfusion of Uncrossmatched Group O Erythrocyte-containing Products Does Not Interfere with Most ABO Typings.

Yazer MH, Spinella PC, Doyle L, Kaufman RM, Dunn R, Hess JR, Filho LA, Fontaine M, Gathof B, Jackson B, Murphy MF, Pasion J, Raval JS, Rosinski K, Seheult J, Shih AW, Sperry J, Staves J, Tuott EE, Ziman A, Triulzi DJ; Biomedical Excellence for Safer Transfusion Collaborative*.

Anesthesiology. 2020 Mar;132(3):525-534. doi: 10.1097/ALN.0000000000003069.

PMID:
31789634
2.

The Impact of an Undergraduate Biology Class on Donor Recruitment at a Hospital-Based Blood Donor Center.

Peedin AR, Park YA, Mazepa MA, Siniard RC, Neish T, Raval JS.

Am J Clin Pathol. 2020 Feb 8;153(3):368-373. doi: 10.1093/ajcp/aqz177.

PMID:
31783402
3.

Total plasma volume determinations for patients with potentially challenging conditions requiring therapeutic plasma exchange: Dealer's choice.

Rosenbaum L, Johnson M, Li M, Raval JS.

J Clin Apher. 2019 Nov 27. doi: 10.1002/jca.21764. [Epub ahead of print] No abstract available.

PMID:
31774189
4.

Therapeutic plasma exchange for neuromyelitis optica spectrum disorder: A multicenter retrospective study by the ASFA neurologic diseases subcommittee.

Ipe TS, Raval JS, Fernando LP, Gokhale A, Jacquot C, Johnson AD, Kim HC, Monis GF, Mo YD, Morgan SM, Pagano MB, Pham HP, Sanford K, Schmidt AE, Schwartz J, Waldman A, Webb J, Winters JL, Wu Y, Yamada C, Wong ECC.

J Clin Apher. 2020 Jan;35(1):25-32. doi: 10.1002/jca.21754. Epub 2019 Nov 9.

PMID:
31705563
5.

Heparin-induced thrombocytopenia associated with collection of hematopoietic progenitor cells by apheresis.

Raval JS, Park YA, Perjar I, Mazepa MA, Vincent BG, Ma AD, Rollins-Raval MA.

J Clin Apher. 2020 Jan;35(1):59-61. doi: 10.1002/jca.21757. Epub 2019 Nov 7.

PMID:
31696530
6.

Taking Empiricism out of Immune Thrombotic Thrombocytopenic Purpura: Current and Future Treatment Strategies.

Mazepa MA, Park YA, Raval JS.

Transfus Med Rev. 2019 Oct;33(4):248-255. doi: 10.1016/j.tmrv.2019.06.005. Epub 2019 Aug 15. Review.

PMID:
31645275
7.

Transfusion as a Palliative Strategy.

Raval JS.

Curr Oncol Rep. 2019 Aug 30;21(10):92. doi: 10.1007/s11912-019-0832-0. Review.

PMID:
31471735
8.

The top 10 things to know about transfusion medicine before intern year: an evidence-based course for graduating medical students.

Peedin AR, Perjar I, Mazepa MA, Rollins-Raval MA, Park YA, Raval JS.

Blood Res. 2019 Jun;54(2):125-130. doi: 10.5045/br.2019.54.2.125. Epub 2019 Jun 25.

9.

Interval decline in hemoglobin A is associated with annual clinical event rate in sickle cell anemia patients receiving maintenance apheresis RBC exchange.

Kamyszek RW, Raval JS, Srinivasan AJ, Ansari AK, Evans BA, Rollins-Raval MA, Poisson JL, Shah NR, Welsby IJ.

Transfusion. 2019 Aug;59(8):2622-2628. doi: 10.1111/trf.15386. Epub 2019 Jun 3.

PMID:
31161685
10.

Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee.

Cohn CS, Allen ES, Cushing MM, Dunbar NM, Friedman DF, Goel R, Harm SK, Heddle N, Hopkins CK, Klapper E, Perumbeti A, Ramsey G, Raval JS, Schwartz J, Shaz BH, Spinella PC, Pagano MB.

Transfusion. 2019 Aug;59(8):2733-2748. doi: 10.1111/trf.15348. Epub 2019 May 30.

PMID:
31148175
11.

Therapeutic plasma exchange for management of heparin-induced thrombocytopenia: Results of an international practice survey.

Onwuemene OA, Zantek ND, Rollins-Raval MA, Raval JS, Kiss JE, Ipe TS, Kuchibhatla M, Pagano MB, Wong ECC.

J Clin Apher. 2019 Oct;34(5):545-554. doi: 10.1002/jca.21709. Epub 2019 May 22.

PMID:
31116461
12.

Comparison of titer results obtained using immediate spin one-dilution techniques to a reference method.

Yazer MH, Dunbar NM, Bub CB, Condict BE, Dunn R, Janoušková M, Kutner J, Landová L, Lejdarová H, Nesvačilová B, Pacasová R, Procházková R, Řehořová L, Raval JS, Ziman A, Bohonĕk M.

Transfusion. 2019 Apr;59(S2):1512-1517. doi: 10.1111/trf.15170.

PMID:
30980760
13.

Micronuclei in Exfoliated Oral Epithelial Cells in Tobacco Users and Controls with Various Oral Lesions: A Study from Gujarat, India.

Wagh A, Raval J, Aiyer RG, Amin S.

Indian J Otolaryngol Head Neck Surg. 2019 Mar;71(1):109-114. doi: 10.1007/s12070-018-1260-4. Epub 2018 Feb 2.

14.

A washer gun plasma system for microwave-plasma interaction experiments.

V P A, Rathod PJ, Raval J, Bahl R, Saxena YC.

Rev Sci Instrum. 2019 Jan;90(1):013502. doi: 10.1063/1.5051802.

PMID:
30709226
15.

Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma, apheresis platelet, and whole blood units tested by different methods.

Harm SK, Yazer MH, Bub CB, Cohn CS, Jacob EK, Kutner JM, Mair DC, Raval JS, Shaz BH, Ziman A, Dunbar NM; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Transfusion. 2019 Feb;59(2):762-767. doi: 10.1111/trf.15083. Epub 2018 Dec 11.

PMID:
30548267
16.

ADAMTS13: origins, applications, and prospects.

Plautz WE, Raval JS, Dyer MR, Rollins-Raval MA, Zuckerbraun BS, Neal MD.

Transfusion. 2018 Oct;58(10):2453-2462. doi: 10.1111/trf.14804. Epub 2018 Sep 12. Review.

PMID:
30208220
17.

Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma Exchange.

Peedin AR, Park YA, Mazepa MA, Rollins-Raval MA, Brecher ME, Raval JS.

Ther Apher Dial. 2018 Dec;22(6):662-665. doi: 10.1111/1744-9987.12713. Epub 2018 Sep 3.

PMID:
30178615
18.

Extracorporeal photopheresis and personalized medicine in the 21st century: The future's so bright!

Raval JS, Ratcliffe NR.

J Clin Apher. 2018 Aug;33(4):461-463. doi: 10.1002/jca.21633. Epub 2018 May 7. No abstract available.

PMID:
29736969
19.

Blood product transfusion and wastage rates in obstetric hemorrhage.

Yazer MH, Dunbar NM, Cohn C, Dillon J, Eldib H, Jackson B, Kaufman R, Murphy MF, O'Brien K, Raval JS, Seheult J, Staves J, Waters JH; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Transfusion. 2018 Jun;58(6):1408-1413. doi: 10.1111/trf.14571. Epub 2018 Mar 7.

PMID:
29516503
20.

Red blood cell transfusion in palliative care: what are we doing and why are we doing it?

Raval JS, Cooling LL.

Transfusion. 2018 Jan;58(1):3-4. doi: 10.1111/trf.14437. No abstract available.

21.

Bortezomib for Refractory Immune-Mediated Thrombocytopenia Purpura.

Beckman JD, Rollins-Raval MA, Raval JS, Park YA, Mazepa M, Ma A.

Am J Ther. 2018 Mar/Apr;25(2):e270-e272. doi: 10.1097/MJT.0000000000000517.

22.

Treatment of acquired Thrombotic Thrombocytopenic Purpura in the U.S. remains heterogeneous: Current and future points of clinical equipoise.

Mazepa MA, Raval JS, Brecher ME, Park YA.

J Clin Apher. 2018 Jun;33(3):291-296. doi: 10.1002/jca.21600. Epub 2017 Nov 18.

PMID:
29150875
23.

Reprioritising transfusion medicine education for graduating medical students.

Peedin AR, Park YA, Raval JS.

Med Educ. 2017 Nov;51(11):1163-1164. doi: 10.1111/medu.13443. Epub 2017 Sep 7. No abstract available.

PMID:
28881025
24.

Anesthesia and Perioperative Care in Reconstructive Transplantation.

Planinsic RM, Raval JS, Gorantla VS.

Anesthesiol Clin. 2017 Sep;35(3):523-538. doi: 10.1016/j.anclin.2017.04.008. Epub 2017 Jul 5. Review.

PMID:
28784224
25.

Should All Massively Transfused Patients Be Treated Equally? An Analysis of Massive Transfusion Ratios in the Nontrauma Setting.

Etchill EW, Myers SP, McDaniel LM, Rosengart MR, Raval JS, Triulzi DJ, Peitzman AB, Sperry JL, Neal MD.

Crit Care Med. 2017 Aug;45(8):1311-1316. doi: 10.1097/CCM.0000000000002498.

PMID:
28537938
26.

Apheresis education in pathology residency.

Peedin AR, Park YA, Raval JS.

J Clin Apher. 2017 Dec;32(6):423-428. doi: 10.1002/jca.21531. Epub 2017 May 9.

PMID:
28485096
27.

Blood product utilization in human upper-extremity transplantation: challenges, complications, considerations, and transfusion protocol conception.

Raval JS, Gorantla VS, Shores JT, Lee WP, Planinsic RM, Rollins-Raval MA, Brandacher G, King KE, Losee JE, Kiss JE.

Transfusion. 2017 Mar;57(3):606-612. doi: 10.1111/trf.14009.

PMID:
28297082
28.

Acute hemolytic transfusion reaction attributed to anti-Ata.

Raval JS, Harm SK, Wagner B, Triulzi DJ, Yazer MH.

Immunohematology. 2016 Dec;32(4):140-142. No abstract available.

PMID:
28257228
29.

Platelet Transfusion in Critical Care and Surgery: Evidence-Based Review of Contemporary Practice and Future Directions.

Etchill EW, Myers SP, Raval JS, Hassoune A, SenGupta A, Neal MD.

Shock. 2017 May;47(5):537-549. doi: 10.1097/SHK.0000000000000794. Review.

PMID:
27849676
30.

Rainbow of hemolysis associated with acquired thrombotic thrombocytopenic purpura.

Raval JS, Mazepa MA, Kim-Shapiro DB, Basu S, Kasthuri RS, Whinna HC, Park YA.

J Clin Apher. 2017 Aug;32(4):274-275. doi: 10.1002/jca.21487. Epub 2016 Aug 17. No abstract available.

31.

Aged Human Stored Red Blood Cell Supernatant Inhibits Macrophage Phagocytosis in an HMGB1 Dependent Manner After Trauma in a Murine Model.

Zettel KR, Dyer M, Raval JS, Wu X, Klune JR, Gutierrez A, Triulzi DJ, Billiar TR, Neal MD.

Shock. 2017 Feb;47(2):217-224. doi: 10.1097/SHK.0000000000000716.

32.

Monitoring therapeutic apheresis utilization: Database versus registry.

Raval JS, Mazepa MA, Whinna HC, Park YA.

J Clin Apher. 2017 Jun;32(3):208-209. doi: 10.1002/jca.21483. Epub 2016 Jul 31. No abstract available.

PMID:
27475704
33.

Extracorporeal photopheresis practice patterns: An international survey by the ASFA ECP subcommittee.

Dunbar NM, Raval JS, Johnson A, Abikoff CM, Adamski J, Cooling LL, Grossman B, Kim HC, Marques MB, Morgan S, Schmidt AE, Sloan SR, Su LL, Szczepiorkowski ZM, West FB, Wong E, Schneiderman J.

J Clin Apher. 2017 Aug;32(4):215-223. doi: 10.1002/jca.21486. Epub 2016 Jul 21.

34.

Factor XIII Subunit A Immunohistochemical Expression is Associated With Inferior Outcomes in Acute Promyelocytic Leukemia.

Raval JS, Berg AN, Djokic M, Roth CG, Rollins-Raval MA.

Appl Immunohistochem Mol Morphol. 2018 Mar;26(3):202-205. doi: 10.1097/PAI.0000000000000404.

PMID:
27299191
35.

Registry development for thrombotic microangiopathies: Biting off more than can be chewed?

Raval JS, Park YA, Wong EC; American Society for Apheresis Clinical Applications Committee.

J Clin Apher. 2017 Feb;32(1):64-65. doi: 10.1002/jca.21464. Epub 2016 Apr 19. No abstract available.

PMID:
27093677
36.

Ramping of pH Across the Water-Pool of a Reverse Micelle.

Mukherjee P, Gupta S, Rafiq S, Yadav R, Jain VK, Raval J, Sen P.

Langmuir. 2016 Feb 23;32(7):1693-9. doi: 10.1021/acs.langmuir.5b04429. Epub 2016 Feb 8.

PMID:
26854978
37.

Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types.

Chartier C, Raval J, Axelrod F, Bond C, Cain J, Dee-Hoskins C, Ma S, Fischer MM, Shah J, Wei J, Ji M, Lam A, Stroud M, Yen WC, Yeung P, Cancilla B, O'Young G, Wang M, Kapoun AM, Lewicki J, Hoey T, Gurney A.

Cancer Res. 2016 Feb 1;76(3):713-23. doi: 10.1158/0008-5472.CAN-15-0561. Epub 2015 Dec 30.

38.

Role of Aspirin and Dexamethasone against Experimentally Induced Depression in Rats.

Bhatt S, Shukla P, Raval J, Goswami S.

Basic Clin Pharmacol Toxicol. 2016 Jul;119(1):10-8. doi: 10.1111/bcpt.12539. Epub 2016 Jan 14.

39.

Correction: Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.

Donahoe M, Valentine VG, Chien N, Gibson KF, Raval JS, Saul M, Xue J, Zhang Y, Duncan SR.

PLoS One. 2015 Jul 20;10(7):e0133684. doi: 10.1371/journal.pone.0133684. eCollection 2015. No abstract available.

40.

Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.

Donahoe M, Valentine VG, Chien N, Gibson KF, Raval JS, Saul M, Xue J, Zhang Y, Duncan SR.

PLoS One. 2015 Jun 17;10(6):e0127771. doi: 10.1371/journal.pone.0127771. eCollection 2015. Erratum in: PLoS One. 2015;10(7):e0133684.

41.

The Role of Colchicine in Pericarditis--A Systematic Review and Meta-analysis of Randomised Trials.

Raval J, Nagaraja V, Eslick GD, Denniss AR.

Heart Lung Circ. 2015 Jul;24(7):660-6. doi: 10.1016/j.hlc.2015.01.010. Epub 2015 Feb 9. Review.

PMID:
25766664
42.

Passive reporting greatly underestimates the rate of transfusion-associated circulatory overload after platelet transfusion.

Raval JS, Mazepa MA, Russell SL, Immel CC, Whinna HC, Park YA.

Vox Sang. 2015 May;108(4):387-92. doi: 10.1111/vox.12234. Epub 2015 Mar 6.

PMID:
25753261
43.

Two cases of asymptomatic massive fetomaternal hemorrhage.

Peedin AR, Mazepa MA, Park YA, Weimer ET, Schmitz JL, Raval JS.

Transfus Apher Sci. 2015 Apr;52(2):208-10. doi: 10.1016/j.transci.2015.01.004. Epub 2015 Jan 26.

PMID:
25736586
44.

Lenalidomide-associated hemolytic anemia.

Lim MY, Raval JS, Richards KL, Zeidner JF, Foster MC.

Leuk Lymphoma. 2015;56(9):2717-9. doi: 10.3109/10428194.2014.1003558. Epub 2015 Mar 2. No abstract available.

PMID:
25644743
45.

Target-vessel versus multivessel revascularisation in ST-elevation myocardial infarction: a meta-analysis of randomised trials.

Sarathy K, Nagaraja V, Kapur A, Szirt R, Raval J, Eslick GD, Burgess D, Denniss AR.

Heart Lung Circ. 2015 Apr;24(4):327-34. doi: 10.1016/j.hlc.2014.10.013. Epub 2014 Dec 5. Review.

PMID:
25547531
46.

Implementation of a simple electronic transfusion alert system decreases inappropriate ordering of packed red blood cells and plasma in a multi-hospital health care system.

Smith M, Triulzi DJ, Yazer MH, Rollins-Raval MA, Waters JH, Raval JS.

Transfus Apher Sci. 2014 Dec;51(3):53-8. doi: 10.1016/j.transci.2014.10.022. Epub 2014 Nov 18.

PMID:
25458903
47.

Silicon drift detector based X-ray spectroscopy diagnostic system for the study of non-thermal electrons at Aditya tokamak.

Purohit S, Joisa YS, Raval JV, Ghosh J, Tanna R, Shukla BK, Bhatt SB.

Rev Sci Instrum. 2014 Nov;85(11):11E419. doi: 10.1063/1.4890406.

PMID:
25430326
48.

Transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis of randomised and non-randomised trials.

Nagaraja V, Raval J, Eslick GD, Ong AT.

Open Heart. 2014 Aug 12;1(1):e000013. doi: 10.1136/openhrt-2013-000013. eCollection 2014.

49.

Massive transfusion protocol activation does not result in preferential use of older red blood cells.

McDaniel LM, Triulzi DJ, Cramer J, Zuckerbraun BS, Sperry JL, Peitzman AB, Raval JS, Neal MD.

J Blood Transfus. 2014;2014:328967. doi: 10.1155/2014/328967. Epub 2014 Sep 10.

50.

Development of a clinically significant ADAMTS13 inhibitor in a patient with hereditary thrombotic thrombocytopenic purpura.

Raval JS, Padmanabhan A, Kremer Hovinga JA, Kiss JE.

Am J Hematol. 2015 Jan;90(1):E22. doi: 10.1002/ajh.23851. Epub 2014 Oct 18. No abstract available.

Supplemental Content

Support Center